Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotorasib +/- Panitumumab Rollover Study in KRAS p.G12C Mutated Cancer
NCT07172919Phase 2Recruiting
- Sponsor
- Amgen
- Start
- Jan 2026
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of sotorasib in solid tumor (advanced stage), sponsored by Amgen. Started Jan 2026; status: recruiting.
02
Drugs
sotorasib
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07172919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07172919.